Skip to main content
Clinical Trials/NCT00363038
NCT00363038CompletedNot Applicable

Effects of Topical Vitamin K, Vitamin K and Retinol, and Arnica on Post-Laser Bruising

Northwestern University1 site in 1 country16 target enrollmentStarted: July 2006Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
16
Locations
1
Primary Endpoint
Average Bruise Change

Study Overview

Brief Summary

The objective of this study is to assess the comparative utility of topical formulations in hastening the resolution of skin bruising. For each subject, four standard bruises of 7 mm diameter each were created on the bilateral upper inner arms, 5 cm apart, two per arm, using a 595-nm pulsed-dye laser. Randomization was used to assign one topical agent (5% vitamin K, 1% vitamin K and 0.3% retinol, 20% arnica or white petrolatum) to exactly one bruise per subject, which was then treated under occlusion twice a day for 2 weeks. A dermatologist rated bruises in standardized photographs immediately after bruise creation and at week 2.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
20 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age 20-60
  • Subjects are in good health.
  • Subjects have willingness and the ability to understand and provide informed consent for participation in the study.

Exclusion Criteria

  • Subjects who are currently using any anticoagulation therapy (Warfarin, Heparin, Aspirin)
  • Subjects who have a history of bleeding disorders.
  • Subjects who are unable to understand the protocol or to give informed consent
  • Subjects with mental illness
  • Subjects who are pregnant or nursing.
  • Subjects who have active systemic or local infection
  • Subjects with systemic or local skin disease.
  • Subjects with systemic illness.

Arms & Interventions

Bruising

Experimental

Bruises at three time points: immediate after bruise creating, and at 1 and 2 weeks.

Intervention: Petrolatum United States Pharmacopeia (USP) (Drug)

Bruising

Experimental

Bruises at three time points: immediate after bruise creating, and at 1 and 2 weeks.

Intervention: Vitamin K and retinol ointment (Drug)

Bruising

Experimental

Bruises at three time points: immediate after bruise creating, and at 1 and 2 weeks.

Intervention: Arnica ointment (Drug)

Bruising

Experimental

Bruises at three time points: immediate after bruise creating, and at 1 and 2 weeks.

Intervention: Vitamin K ointment (Drug)

Outcomes

Primary Outcomes

Average Bruise Change

Time Frame: Baseline and 2 weeks

Mean change in bruising level detected by dermatologist rater on Visual Analogue Scale at 2 weeks compared with baseline for each of the four agents (Petrolatum USP, Vitamin K and retinol ointment, Vitamin K ointment, Arnica ointment). When responding to a VAS item, respondents specify the bruise severity by indicating a position along a continuous line between two end-points (0 and 10, 10 being the most bruised).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Murad Alam

Associate Professor of Dermatology

Northwestern University

Study Sites (1)

Loading locations...

Similar Trials